This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : dbbc93f0-250f-458c-914f-0c59d4ce
Credit: Tima Miroshnichenko from Pexels Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. The drug, called Cobenfy and developed
Almost half of patients diagnosed with depression classify as being ‘treatment-resistant’ as new research suggests that many don’t respond to multiple antidepressant options. The new study, published in the British
Use of psilocybin, the hallucinogenic chemical found in what is known as “magic mushrooms,” has increased significantly nationwide since 2019, according to a new study led by researchers at the
